Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097435
Status:
COMPLETED
Last Update Posted:
2013-08-02
First Post:
2004-11-23
Brief Title:
A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C
Sponsor:
Human Genome Sciences Inc
Organization:
Human Genome Sciences Inc
Study Overview
Official Title:
A Multi-Center Randomized Open-Label Study to Evaluate the Safety Tolerability and Efficacy of Albuferon Recombinant Human Albumin-Interferon Alfa Fusion Protein in Combination With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 2 multi-center randomized open-label study to evaluate the safety tolerability and efficacy of Albuferon in subjects with hepatitis C HEP C who failed to respond to previous interferon alfa therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None